287 related articles for article (PubMed ID: 19336268)
1. Determination of pharmaceutical compounds in hospital effluents and their contribution to wastewater treatment works.
Langford KH; Thomas KV
Environ Int; 2009 Jul; 35(5):766-70. PubMed ID: 19336268
[TBL] [Abstract][Full Text] [Related]
2. Source to sink tracking of selected human pharmaceuticals from two Oslo city hospitals and a wastewater treatment works.
Thomas KV; Dye C; Schlabach M; Langford KH
J Environ Monit; 2007 Dec; 9(12):1410-8. PubMed ID: 18049781
[TBL] [Abstract][Full Text] [Related]
3. Determination of pharmaceuticals of various therapeutic classes by solid-phase extraction and liquid chromatography-tandem mass spectrometry analysis in hospital effluent wastewaters.
Gómez MJ; Petrović M; Fernández-Alba AR; Barceló D
J Chromatogr A; 2006 May; 1114(2):224-33. PubMed ID: 16546199
[TBL] [Abstract][Full Text] [Related]
4. Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment.
Verlicchi P; Al Aukidy M; Galletti A; Petrovic M; Barceló D
Sci Total Environ; 2012 Jul; 430():109-18. PubMed ID: 22634557
[TBL] [Abstract][Full Text] [Related]
5. Determining the fraction of pharmaceutical residues in wastewater originating from a hospital.
Ort C; Lawrence MG; Reungoat J; Eaglesham G; Carter S; Keller J
Water Res; 2010 Jan; 44(2):605-15. PubMed ID: 19717180
[TBL] [Abstract][Full Text] [Related]
6. Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures.
Sim WJ; Lee JW; Lee ES; Shin SK; Hwang SR; Oh JE
Chemosphere; 2011 Jan; 82(2):179-86. PubMed ID: 21040946
[TBL] [Abstract][Full Text] [Related]
7. Preliminary study of physico-chemical treatment options for hospital wastewater.
Gautam AK; Kumar S; Sabumon PC
J Environ Manage; 2007 May; 83(3):298-306. PubMed ID: 16824671
[TBL] [Abstract][Full Text] [Related]
8. Healthcare facility effluents as point sources of select pharmaceuticals to municipal wastewater.
Nagarnaik PM; Batt AL; Boulanger B
Water Environ Res; 2012 Apr; 84(4):339-45. PubMed ID: 22834222
[TBL] [Abstract][Full Text] [Related]
9. Quantification of human pharmaceuticals in water samples by high performance liquid chromatography-tandem mass spectrometry.
Nebot C; Gibb SW; Boyd KG
Anal Chim Acta; 2007 Aug; 598(1):87-94. PubMed ID: 17693311
[TBL] [Abstract][Full Text] [Related]
10. The treatment of hospital wastewater: an appraisal.
Pauwels B; Verstraete W
J Water Health; 2006 Dec; 4(4):405-16. PubMed ID: 17176811
[TBL] [Abstract][Full Text] [Related]
11. Comparison of contaminants of emerging concern removal, discharge, and water quality hazards among centralized and on-site wastewater treatment system effluents receiving common wastewater influent.
Du B; Price AE; Scott WC; Kristofco LA; Ramirez AJ; Chambliss CK; Yelderman JC; Brooks BW
Sci Total Environ; 2014 Jan; 466-467():976-84. PubMed ID: 23988745
[TBL] [Abstract][Full Text] [Related]
12. Occurrence and removal of pharmaceuticals, caffeine and DEET in wastewater treatment plants of Beijing, China.
Sui Q; Huang J; Deng S; Yu G; Fan Q
Water Res; 2010 Jan; 44(2):417-26. PubMed ID: 19674764
[TBL] [Abstract][Full Text] [Related]
13. Drugs, diagnostic agents and disinfectants in wastewater and water--a review.
Kümmerer K
Schriftenr Ver Wasser Boden Lufthyg; 2000; 105():59-71. PubMed ID: 10842795
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of pharmaceuticals in Taiwan's surface waters: impact of waste streams from hospitals and pharmaceutical production facilities.
Lin AY; Tsai YT
Sci Total Environ; 2009 Jun; 407(12):3793-802. PubMed ID: 19345984
[TBL] [Abstract][Full Text] [Related]
15. Analysis of pharmaceuticals in indirect potable reuse systems using solid-phase extraction and liquid chromatography-tandem mass spectrometry.
Busetti F; Linge KL; Heitz A
J Chromatogr A; 2009 Jul; 1216(31):5807-18. PubMed ID: 19560149
[TBL] [Abstract][Full Text] [Related]
16. Occurrence and removal of pharmaceuticals in wastewater treatment plants at the Spanish Mediterranean area of Valencia.
Gracia-Lor E; Sancho JV; Serrano R; Hernández F
Chemosphere; 2012 Apr; 87(5):453-62. PubMed ID: 22221664
[TBL] [Abstract][Full Text] [Related]
17. Modeling of hospital wastewater pollution by pharmaceuticals: first results of Mediflux study carried out in three French hospitals.
Mullot JU; Karolak S; Fontova A; Levi Y
Water Sci Technol; 2010; 62(12):2912-9. PubMed ID: 21123922
[TBL] [Abstract][Full Text] [Related]
18. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain).
Santos JL; Aparicio I; Alonso E
Environ Int; 2007 May; 33(4):596-601. PubMed ID: 17084895
[TBL] [Abstract][Full Text] [Related]
19. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
Radjenović J; Petrović M; Barceló D
Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
[TBL] [Abstract][Full Text] [Related]
20. Influence of residual organic macromolecules produced in biological wastewater treatment processes on removal of pharmaceuticals by NF/RO membranes.
Kimura K; Iwase T; Kita S; Watanabe Y
Water Res; 2009 Aug; 43(15):3751-8. PubMed ID: 19564034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
